SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-243702
Filing Date
2022-09-13
Accepted
2022-09-13 16:05:57
Documents
16
Period of Report
2022-09-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d397120d8k.htm   iXBRL 8-K 25380
2 EX-99.1 d397120dex991.htm EX-99.1 14910
3 EX-99.2 d397120dex992.htm EX-99.2 16713
7 GRAPHIC g397120dsp001.jpg GRAPHIC 3882
8 GRAPHIC g397120g0913091940911.jpg GRAPHIC 3274
  Complete submission text file 0001193125-22-243702.txt   201782

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA alny-20220912.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20220912_lab.xml EX-101.LAB 17996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20220912_pre.xml EX-101.PRE 11263
10 EXTRACTED XBRL INSTANCE DOCUMENT d397120d8k_htm.xml XML 3376
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 221240807
SIC: 2834 Pharmaceutical Preparations